Astrana Competitors

Delisted . USA . 
Stock . Astrana Health
AMEHDelisted Stock  USD 34.07  0.34  0.99%   
Astrana Health competes with Acadia Healthcare, Select Medical, InnovAge Holding, Lifestance Health, and Ensign; as well as few others. The company conducts business under Health Care Providers & Services sector and is part of Health Care industry. Analyzing Astrana Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Astrana Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Astrana Health competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Astrana Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
34.0734.0734.07
Details
Intrinsic
Valuation
LowRealHigh
28.4328.4337.48
Details
Naive
Forecast
LowNextHigh
35.4935.4935.49
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
29.3732.3835.40
Details

Astrana Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Astrana Health and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Astrana and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Astrana Health does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
SGRY
+ 0.89
ADUS
OPCH
+ 0.88
ACHC
UHS
+ 0.87
ACHC
OPCH
+ 0.87
UHS
SGRY
+ 0.83
INNV
ADUS
+ 0.81
UHS
  
High negative correlations   
OPCH
- 0.86
EHC
EHC
- 0.83
ACHC
EHC
- 0.69
UHS
OPCH
- 0.67
SEM
LFST
- 0.65
ACHC
SGRY
- 0.6
SEM

Risk-Adjusted Indicators

There is a big difference between Astrana Stock performing well and Astrana Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Astrana Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ACHC  2.25 (1.08) 0.00 (0.82) 0.00 
 0.00 
 3.36 
(5.78)
 21.88 
SEM  1.59 (0.03) 0.02  0.11  1.84 
(1.67)
 3.01 
(2.51)
 16.75 
INNV  2.18 (0.55) 0.00 (0.20) 0.00 
 0.00 
 4.23 
(4.81)
 11.60 
LFST  1.55  0.17  0.09  0.30  1.56 
(1.71)
 3.28 
(3.30)
 11.88 
ENSG  1.05  0.01  0.00  0.08  0.00 
 0.00 
 2.32 
(2.11)
 10.08 
UHS  1.38 (0.26) 0.00 (0.49) 0.00 
 0.00 
 2.40 
(4.07)
 14.88 
ADUS  1.26 (0.25) 0.00 (0.10) 0.00 
 0.00 
 2.50 
(2.51)
 7.98 
EHC  0.91  0.13  0.05  0.49  0.83 
(0.98)
 1.74 
(1.86)
 9.75 
SGRY  2.11 (0.56) 0.00 (0.36) 0.00 
 0.00 
 3.72 
(4.88)
 17.97 
OPCH  1.79 (0.59) 0.00 (0.21) 0.00 
 0.00 
 2.91 
(3.57)
 26.20 
All Fundamental Data

Astrana Health Competitive Analysis

The better you understand Astrana Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Astrana Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Astrana Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AMEH ACHC SEM INNV LFST ENSG UHS ADUS EHC SGRY
 0.99 
 34.07 
Astrana
 1.57 
 40.63 
Acadia
 3.73 
 21.11 
Select
 1.46 
 4.87 
InnovAge
 0.13 
 7.52 
Lifestance
 0.16 
 146.21 
Ensign
 0.74 
 205.00 
Universal
 1.28 
 122.84 
Addus
 0.1 
 102.94 
Encompass
 1.84 
 23.84 
Surgery
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Slightly risky
Somewhat reliable
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Modest
Very Weak
OK
Very Weak
Very Weak
Very Weak
OK
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Below Average
Low
Low
Below Average
Low
Low
Very Low
Low
Below Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Under Valued
Under Valued
Fairly Valued
Fairly Valued
Fairly Valued
Fairly Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Buy
Strong Buy
Hold
Buy
Strong Buy
Buy
Strong Buy
Strong Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Sell
Hold
Hold
Strong Hold
Strong Sell
Strong Sell
Hold
Hold
Cautious Hold
Current Ratio
2.49
1.17
1.02
2.29
2.19
1.28
1.27
2.0
1.21
1.51
Net Asset
966.21 M
5.36 B
7.69 B
547.66 M
2.23 B
4.18 B
13.97 B
1.02 B
6.1 B
6.88 B
Profit Margin
0.0336
0.0899
0.0397
-0.0203
-0.079
0.0584
0.0666
0.065
0.081
-0.0203
EBITDA
117.97 M
189.11 M
763.62 M
1.15 M
(104.93 M)
353.24 M
1.71 B
106.56 M
1.02 B
480.8 M
Operating Margin
0.11
0.18
0.0801
-0.0239
0.0013
0.0826
0.0969
0.0896
0.15
0.13
Current Valuation
1.81 B
5.7 B
7.1 B
683.94 M
3.26 B
9.82 B
18.52 B
2.05 B
13.02 B
6.33 B
Price To Book
3.12
1.24
1.42
2.53
2.0
4.79
2.05
2.35
5.29
1.6
Retained Earnings
192.68 M
131.72 M
751.86 M
(68.31 M)
(760.85 M)
1.14 B
6.8 B
302.83 M
406.5 M
(569.2 M)
Current Asset
13.56 M
294.74 M
749.15 M
3.06 M
N/A
279.57 M
1.72 B
102.56 M
659.58 M
310.96 M
Five Year Return
N/A
N/A
N/A
N/A
N/A
0.39
0.43
N/A
1.65
N/A
Beta
1.04
1.33
1.42
0.39
1.24
0.95
1.3
1.04
0.78
2.77
Number Of Employees
1.36 K
17 K
38.4 K
2.35 K
7.27 K
35.3 K
96.7 K
6.06 K
27.48 K
10.5 K
Shares Outstanding
45.45 M
92.89 M
128.99 M
135.46 M
382.64 M
57.3 M
58.71 M
18.13 M
100.75 M
127.11 M
Cash Flow From Operations
133.87 M
462.34 M
582.06 M
(36.9 M)
(16.88 M)
376.67 M
1.27 B
112.25 M
850.8 M
293.8 M
Annual Yield
N/A
N/A
0.0237
N/A
N/A
0.0016
0.0039
N/A
0.0066
N/A
Total Debt
229.36 M
1.51 B
4.96 B
113.03 M
511.04 M
1.87 B
5.37 B
175.18 M
2.93 B
3.06 B
Return On Equity
0.0976
0.0976
0.18
-0.0603
-0.0659
0.15
0.16
0.0903
0.23
0.0308
Z Score
7.27
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
0.0626
0.0606
0.0484
-0.0202
-0.0156
0.0402
0.0682
0.0627
0.0838
0.039
Number Of Shares Shorted
2.75 M
6.55 M
1.79 M
303.26 K
12.29 M
2.21 M
1.53 M
453.16 K
1.1 M
10.07 M
Book Value Per Share
12.74
33.04
14.79
1.93
3.76
30.71
100.14
52.85
19.44
15.0
Current Liabilities
7.43 M
290.2 M
729.28 M
4.22 M
N/A
179.87 M
1.1 B
42.19 M
474.74 M
181.29 M
Total Asset
966.21 M
5.36 B
7.69 B
547.66 M
2.23 B
4.18 B
13.97 B
1.02 B
6.1 B
6.88 B
Debt To Equity
0.42
0.58
3.68
0.24
0.13
1.25
0.87
0.41
1.69
1.44
Short Ratio
17.16
3.59
2.84
10.01
7.77
4.86
1.81
3.48
1.5
10.96
Target Price
46.56
60.17
38.75
7.0
8.3
169.5
240.81
136.6
115.67
36.29
Last Dividend Paid
N/A
N/A
0.5
N/A
N/A
0.24
0.8
N/A
0.62
N/A
Shares Owned By Institutions
46.99
97.03
78.97
11.9
91.23
96.57
94.0
98.25
98.16
98.88
Market Capitalization
1.86 B
3.83 B
2.72 B
659.67 M
2.88 B
8.38 B
13.52 B
2.23 B
10.37 B
3.03 B
Price To Earning
28.18
25.67
13.33
33.64
N/A
29.5
13.68
51.96
18.73
61.84
Price To Earnings To Growth
N/A
1.32
1.37
N/A
N/A
1.58
1.87
1.35
1.37
1.66
Price To Sales
1.4
1.23
0.39
0.84
2.39
2.04
0.88
1.96
1.99
1.02
Net Income
48.51 M
(21.67 M)
299.73 M
(23.22 M)
(186.26 M)
209.85 M
717.49 M
62.52 M
361.6 M
(11.9 M)
Earnings Per Share
1.04
3.05
2.14
-0.12
-0.25
4.12
15.03
4.37
4.25
-0.47
Shares Owned By Insiders
25.77
2.97
17.32
85.03
11.11
3.29
4.25
1.75
1.36
1.12
Revenue
1.33 B
2.93 B
6.66 B
763.86 M
1.06 B
3.73 B
14.28 B
1.06 B
4.8 B
2.74 B
Working Capital
287.81 M
(289.78 M)
9.18 M
34.54 M
22.86 M
312.18 M
798 M
54.89 M
185.4 M
372 M
Cash And Equivalents
273.71 M
128.37 M
97.91 M
184.43 M
96.69 M
321.1 M
102.82 M
120.92 M
21.8 M
227.4 M
Cash Per Share
6.04
1.41
1.35
1.36
0.26
5.79
1.04
7.59
0.6
2.58
Gross Profit
199.48 M
1.12 B
1.1 B
475.82 M
237.02 M
534.92 M
5.16 B
299.74 M
1.75 B
574.9 M
Day Typical Price
34.28
40.93
20.9
4.83
7.55
146.14
204.07
122.55
102.8
23.71
Accumulation Distribution
0.0275
0.0267
0.0382
0.0246
0.0248
0.012
0.016
0.018
0.0122
0.0378
Market Facilitation Index
0.96
1.11
0.81
0.12
0.19
1.76
3.29
2.22
1.26
0.91
Daily Balance Of Power
(0.35)
(0.59)
0.9383
0.5833
0.0526
0.1307
0.4559
0.6982
0.0794
0.4725
Period Momentum Indicator
(0.34)
(0.65)
0.76
0.07
0.01
0.23
1.5
1.55
0.1
0.43
Rate Of Daily Change
0.99
0.98
1.04
1.01
1.0
1.0
1.01
1.01
1.0
1.02
Day Median Price
34.38
41.09
20.8
4.81
7.57
146.1
203.61
122.41
102.73
23.65
Price Action Indicator
(0.48)
(0.78)
0.69
0.095
(0.04)
0.23
2.14
1.21
0.26
0.41
Coefficient Of Variation
(1,362)
(413.68)
1334.77
(854.32)
682.88
(11,029)
(1,063)
(1,683)
728.63
(730.20)
Mean Deviation
2.14
2.25
1.59
2.18
1.55
1.05
1.38
1.26
0.9065
2.11
Jensen Alpha
(0.31)
(1.08)
(0.03)
(0.55)
0.1682
0.014
(0.26)
(0.25)
0.1326
(0.56)
Total Risk Alpha
(0.70)
(1.57)
(0.22)
(0.79)
(0.05)
(0.27)
(0.55)
(0.38)
(0.05)
(0.90)
Sortino Ratio
N/A
N/A
0.0183
N/A
0.0867
N/A
N/A
N/A
0.0481
N/A
Downside Variance
N/A
N/A
4.09
N/A
3.69
N/A
N/A
N/A
1.17
N/A
Standard Deviation
2.88
3.83
2.33
2.76
2.08
1.49
2.08
1.64
1.38
2.93
Kurtosis
1.41
9.76
9.6
(0.15)
1.57
5.96
6.57
1.2
10.68
5.63
Potential Upside
4.26
3.36
3.01
4.23
3.28
2.32
2.4
2.5
1.74
3.72
Treynor Ratio
(0.32)
(0.82)
0.1099
(0.20)
0.298
0.0799
(0.49)
(0.1)
0.4863
(0.36)
Maximum Drawdown
14.65
21.88
16.75
11.6
11.88
10.08
14.88
7.98
9.75
17.97
Variance
8.32
14.65
5.43
7.6
4.31
2.22
4.32
2.68
1.91
8.6
Market Risk Adjusted Performance
(0.31)
(0.81)
0.1199
(0.19)
0.308
0.0899
(0.48)
(0.09)
0.4963
(0.35)
Risk Adjusted Performance
(0.05)
(0.18)
0.064
(0.08)
0.1183
(0)
(0.07)
(0.04)
0.1094
(0.1)
Skewness
(0.68)
(2.70)
1.86
0.0468
0.5519
(1.02)
(1.57)
0.4923
2.12
(1.55)
Semi Deviation
N/A
N/A
1.84
N/A
1.56
N/A
N/A
N/A
0.8295
N/A
Information Ratio
(0.12)
(0.28)
0.0159
(0.17)
0.0802
(0.10)
(0.16)
(0.14)
0.0377
(0.18)
Value At Risk
(5.40)
(5.78)
(2.51)
(4.81)
(3.30)
(2.11)
(4.07)
(2.51)
(1.86)
(4.88)
Expected Short fall
N/A
N/A
(1.67)
N/A
(1.71)
N/A
N/A
N/A
(0.98)
N/A
Downside Deviation
N/A
N/A
2.02
N/A
1.92
N/A
N/A
N/A
1.08
N/A
Semi Variance
N/A
N/A
3.4
N/A
2.44
N/A
N/A
N/A
0.6881
N/A

Astrana Health Competition Performance Charts

Five steps to successful analysis of Astrana Health Competition

Astrana Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Astrana Health in relation to its competition. Astrana Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Astrana Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Astrana Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Astrana Health, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Astrana Health position

In addition to having Astrana Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Business Supplies Thematic Idea Now

Business Supplies
Business Supplies Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Business Supplies theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Business Supplies Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Consideration for investing in Astrana Stock

If you are still planning to invest in Astrana Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Astrana Health's history and understand the potential risks before investing.
Transaction History
View history of all your transactions and understand their impact on performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY